These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1038 related articles for article (PubMed ID: 19646078)

  • 1. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T; Marklund B
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical care in community pharmacies: practice and research in Sweden.
    Westerlund LT; Björk HT
    Ann Pharmacother; 2006 Jun; 40(6):1162-9. PubMed ID: 16735653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug related problems identified by European community pharmacists in patients discharged from hospital.
    Paulino EI; Bouvy ML; Gastelurrutia MA; Guerreiro M; Buurma H;
    Pharm World Sci; 2004 Dec; 26(6):353-60. PubMed ID: 15683106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of drug-related problems identified by community pharmacies.
    Hämmerlein A; Griese N; Schulz M
    Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoting appropriate drug use through the application of the Spanish drug-related problem classification system in the primary care setting.
    Gómez MA; Villafaina A; Hernández J; Salgado RM; González MA; Rodríguez J; Martínez de la Concha M; Tarriño A; Gervasini G; Carrillo JA
    Ann Pharmacother; 2009 Feb; 43(2):339-46. PubMed ID: 19193590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of patients receiving a pharmaceutical care service in Sweden.
    Montgomery AT; Sporrong SK; Tully MP; Lindblad AK
    J Clin Pharm Ther; 2008 Dec; 33(6):653-62. PubMed ID: 19138243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of community pharmacists in providing clinical medication reviews.
    Laaksonen R; Duggan C; Bates I
    Ann Pharmacother; 2010; 44(7-8):1181-90. PubMed ID: 20571102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-related problems detected in Australian Community Pharmacies: The PROMISe Trial.
    Williams M; Peterson GM; Tenni PC; Bindoff IK; Curtain C; Hughes J; Bereznicki LR; Jackson SL; Kong DC; Hughes JD
    Ann Pharmacother; 2011 Sep; 45(9):1067-76. PubMed ID: 21878658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmaceutical care for drug-related problems in inpatients].
    Gorgas Torner MQ; Odena Estradé E; Pastor Solernou F
    Farm Hosp; 2003; 27(5):280-9. PubMed ID: 14576917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-related problems at discharge: results on the Spanish pharmacy discharge programme CONSULTENOS.
    López MP; Saliente MT; Company ES; Monsalve AG; Cueva MA; Domingo EA; Hernández MM; Carrión CC; Martí MC; Querejeta NB; Blasco JB; Milá AR
    Int J Pharm Pract; 2010 Oct; 18(5):297-304. PubMed ID: 20840686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study.
    Pai AB; Boyd A; Depczynski J; Chavez IM; Khan N; Manley H
    Pharmacotherapy; 2009 Dec; 29(12):1433-40. PubMed ID: 19947803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacists' performance of clinical interventions during adherence support medication reviews.
    Hatah E; Tordoff J; Duffull SB; Braund R
    Res Social Adm Pharm; 2014; 10(1):185-94. PubMed ID: 23688540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective analysis of drug-related problems documented in a national database.
    Westerlund T; Gelin U; Pettersson E; Skärlund F; Wågström K; Ringbom C
    Int J Clin Pharm; 2013 Apr; 35(2):202-9. PubMed ID: 23187961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of services provided by pharmacists in the Iowa Medicaid Pharmaceutical Case Management program.
    Carter BL; Chrischilles EA; Scholz D; Hayase N; Bell N
    J Am Pharm Assoc (Wash); 2003; 43(1):24-33. PubMed ID: 12585748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical pharmacist in a multidisciplinary team in a paediatric department].
    Kjeldby C; Bjerre A; Refsum N
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1746-9. PubMed ID: 19756055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The health care cost of drug-related morbidity and mortality in nursing facilities.
    Bootman JL; Harrison DL; Cox E
    Arch Intern Med; 1997 Oct; 157(18):2089-96. PubMed ID: 9382665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a pharmacy resident on hospital length of stay and drug-related costs.
    Terceros Y; Chahine-Chakhtoura C; Malinowski JE; Rickley WF
    Ann Pharmacother; 2007 May; 41(5):742-8. PubMed ID: 17440008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and safety-relevance of drug-related problems in German community pharmacies.
    Lewinski D; Wind S; Belgardt C; Plate V; Behles C; Schweim HG
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):141-9. PubMed ID: 19777534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.